Global Pre-filled Syringes Market 2017-2021

SKU ID :TNV-10886202 | Published Date: 05-Jul-2017 | No. of pages: 94
PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Market outline PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by material type • Market overview • Market size and forecast • Glass pre-filled syringes • Plastic pre-filled syringes PART 07: Market segmentation by application • Market overview • Market size and forecast • Insulin pre-filled syringes • Vaccine pre-filled syringes • Anticoagulants pre-filled syringes • Others PART 08: Market segmentation by end-user • Market size and forecast • Hospitals and clinics • Home healthcare PART 09: Geographical segmentation • Market size and forecast • EMEA • Americas • APAC PART 10: Decision framework PART 11: Drivers and challenges • Market drivers • Market challenges PART 12: Market trends • Shift from glass pre-filled syringes to plastic pre-filled syringes • Change in strategy for introduction of drug pre-filled syringes into the market • Innovations in pre-filled syringes • Increasing demand for auto-injector/pre-filled syringes combination devices PART 13: Vendor landscape • Competitive landscape PART 14: Key vendor analysis • Baxter • BD • Gerresheimer • SCHOTT • TERUMO • Other prominent vendors PART 15: Appendix • List of abbreviations List of Exhibits  Exhibit 01: Global pre-filled syringes market segmentation Exhibit 02: Global pre-filled syringes market 2016-2021 ($ millions) Exhibit 03: Five forces analysis Exhibit 04: Pre-filled syringes available in the market Exhibit 05: Global pre-filled syringes market share by material type 2016 (%) Exhibit 06: Global glass pre-filled syringes market 2016-2021 ($ millions) Exhibit 07: Global plastic pre-filled syringes market 2016-2021 ($ millions) Exhibit 08: Pre-filled syringes market opportunities in key applications Exhibit 09: Global pre-filled syringes market share by application 2016 (%) Exhibit 10: Global insulin pre-filled syringes market: Overview Exhibit 11: Global vaccine pre-filled syringes market: Overview Exhibit 12: Global anticoagulants pre-filled syringes market: Overview Exhibit 13: Drugs in pre-filled syringes marketed for other diseases Exhibit 14: Drugs in pre-filled syringes in clinical trials for other diseases Exhibit 15: Global pre-filled syringes market by end-users 2016 (%) Exhibit 16: Factors influencing the adaptation of pre-filled syringes in hospitals and clinics Exhibit 17: Factors influencing the adaptation of pre-filled syringes in home healthcare Exhibit 18: Global pre-filled syringes market by geography 2016 (%) Exhibit 19: Pre-filled syringes market in EMEA 2016-2021: Overview Exhibit 20: Pre-filled syringes market in EMEA 2016-2021 ($ millions) Exhibit 21: Pre-filled syringes market in Americas 2016-2021: Overview Exhibit 22: Pre-filled syringes market in Americas 2016-2021 ($ millions) Exhibit 23: Pre-filled syringes market in APAC 2016-2021: Overview Exhibit 24: Pre-filled syringes market in APAC 2016-2021 ($ millions) Exhibit 25: Baxter: Key highlights Exhibit 26: Baxter: Strength assessment Exhibit 27: Baxter: Strategy assessment Exhibit 28: Baxter: Opportunity assessment Exhibit 29: BD: Key highlights Exhibit 30: BD: Strength assessment Exhibit 31: BD: Strategy assessment Exhibit 32: BD: Opportunity assessment Exhibit 33: Gerresheimer: Key highlights Exhibit 34: Gerresheimer: Strength assessment Exhibit 35: Gerresheimer: Strategy assessment Exhibit 36: Gerresheimer: Opportunity assessment Exhibit 37: SCHOTT: Key highlights Exhibit 38: SCHOTT: Strength assessment Exhibit 39: SCHOTT: Strategy assessment Exhibit 40: SCHOTT: Opportunity assessment Exhibit 41: TERUMO: Key highlights Exhibit 42: TERUMO: Strength assessment Exhibit 43: TERUMO: Strategy assessment Exhibit 44: TERUMO: Opportunity assessment Exhibit 45: Other prominent vendors
BD, Gerresheimer, SCHOTT, Baxter, and TERUMO. AptarGroup, Bespak, Medtronic Minimally Invasive Therapies (formerly known as Covidien), NIPRO, SHL Group, STERINOVA, UNILIFE, Vetter Pharma-Fertigung GmbH & Co., and West Pharmaceutical Services.
  • PRICE
  • $2500
    $4000

Our Clients